US Patent

US7960370 — Type A gelatin capsule containing PUFA in free acid form

Formulation · Assigned to Individual · Expires 2026-12-20 · 1y remaining

Vulnerability score 65/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a soft gelatin capsule containing omega-3 polyunsaturated fatty acids in free acid form, made with gelatin extracted using an acid pre-treatment process.

USPTO Abstract

A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterized in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life.

Drugs covered by this patent

Patent Metadata

Patent number
US7960370
Jurisdiction
US
Classification
Formulation
Expires
2026-12-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.